Abstract
(Abstracted from Prev Med 2021;143:106387) Despite significant improvement through the past decade in implementation and adoption of cervical cancer screening and prevention worldwide, in 2018, the global age standardized incidence and mortality rates were 13.1 and 6.9 per 100,000 women, respectively. Current screening guidelines suggest a papillomavirus test (Papanicolaou test) every 3 years for women aged 21 through 65 years.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
